Tag: Prescription Drugs
One-Third of Hep C Rx Receive Absolute Denial From Insurers
Both private and public insurers continue to deny coverage for drugs at high rates
Sulfonylureas As 2nd-Line T2DM Therapy Tied to Higher Event Risk
Associated with increased risk of myocardial infarction, all-cause mortality, severe hypoglycemia
CDC: More People With High Cholesterol Taking Medications
Findings only among men and women over 60 years, not younger patients with high cholesterol
Walmart Generic Drug Discounts Often Offer More Patient Savings
Walmart drug program offers savings over Medicare program for generic cardiovascular medications
Empagliflozin Doesn’t Up Risk of Bone Fractures
Per pooled data from placebo-controlled trials and data from a head-to-head study with glimepiride
Availability of Generic Antivirals for Hepatitis B Increasing
Drop in median price of WHO-prequalified generic tenofovir from $208 to $32 from 2004 to 2016
L-Glutamine Reduces Number of Pain Crises in Sickle Cell Disease
Significantly fewer pain crises, hospitalizations compared with those receiving placebo
Basal Insulin Analogues Similar for Glucose Lowering
Slight differences in risk for nocturnal hypoglycemia or weight gain exist
Testosterone Prescribing Down Since 2013
Decline coincided with reports linking testosterone to adverse cardiovascular events
Evidence of Clinical Inertia in Management of T2DM
No treatment intensification for many patients with HbA1c threshold expected to trigger intensification
